The Cancer Industry Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of The Cancer Industry book. This book definitely worth reading, it is an incredibly well-written.
"By the time you're done reading this book, you'll know: if surgery, chemotherapy or radiotherapy are effective treatments for cancer; if cancer screening programs save lives or result in mass over-diagnosis and over-treatment; if the cancer industry has suppressed cures or effective treatments from the public"--Back cover.
From the National Book Award finalist and author of "When Smoke Ran Like Water" comes this searing, haunting, and deeply personal account of how a major public health effort was diverted and distorted for private gain.
Where is The Cure for Cancer? Have you ever wondered why in the past 100 years a cure for cancer has not been found? You're not alone! We've all lost someone we love to cancer and we all want to see it gone. But after spending $500 Billion dollars of our generous donations on cancer research over the past 50 years, the people who promised us a cure have given us literally nothing for preventing or curing the disease. Are they incompetent? Or are cures and effective treatments purposefully being suppressed so the industry can keep raking in money? It's time to find out the truth. The Truth About Cancer After losing his mother to cancer at age 12, bestselling author Mark Sloan has conducted a historic and monumental investigation into The Cancer Industry to find out why she died such an agonizing death. I'm here to ask the difficult questions. Did my mother die of cancer? Or was she murdered for-profit by an industry that cares more about making money than saving lives? Backed by evidence from over 600 scientific and clinical references, The Cancer Industry will guide you on a journey into cancer treatments - surgery, chemotherapy and radiotherapy - as well as cancer screening tests - Mammography and The PSA Test. Do they actually work or are they doing us more harm than good?
Never Fear Cancer Again What if I told you that all the research needed to end the disease of cancer forever has already been completed? Would you believe it? Well now you don't have to! Cancer: The Metabolic Disease Unravelled is your complete guide to the revolutionary scientific discoveries made over the past 150 years that reveal exactly what cancer is, what cancer isn't, and the most efficient ways to heal it - without causing patients any harm whatsoever in the process. Bestselling author Mark Sloan lost his mother to cancer when he was 12 years old and now he's made it his life mission to ensure that no child has to go through what he did, ever again. Pick up your copy now by clicking the BUY NOW button at the top of this page!
This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer—and how we can avoid repeating the policy and practice mistakes of the past.
This book examines the politics of cancer, explains how our government is intrinsically tied to cancer research efforts, and documents how major political actors make cancer policy and are influenced in their decision making by political, social, scientific, and economic variables. Is whether we contract cancer—and whether we survive the disease, if we get it—largely just a result of good versus bad luck, or are these outcomes regarding cancer tied to the policies and actions of our federal government? Cancer-treating drug development and approval is overseen by the U.S. Food and Drug Administration, billions of dollars of federal money are devoted towards cancer research, and exposure of citizens to potentially cancer-causing environments or chemicals is regulated by the Environmental Protection Agency. Additionally, all of these factors can be affected by the political motivations of our most powerful politicians. The Politics of Cancer: Malignant Indifference analyzes the policy environment of cancer in America: the actors, the political institutions, the money, and the disease itself, identifying how haphazard U.S. government policy toward cancer research has been and how the president, Congress, government bureaucracies, and even the cancer industry have failed to meet timelines and make the expected discoveries. Whitman Cobb examines funding for the National Cancer Institute and the roles of the executive, Congress, policy entrepreneurs, and the bureaucracy as well as that of the state of cancer science. She argues that despite the so-called "war on cancer," no strategic, comprehensive government policy has been imposed—leading to an indecisive cancer policy that has significantly impeded cancer research. Written from a political science perspective, the book enables readers to gain insight into the realities of science policy and the ways in which the federal government is both the source of funding for much of cancer research and often deficient in setting comprehensive and consistent anti-cancer policy. Readers will also come to understand how Congress, the president, the bureaucracy, and the cancer industry all share responsibility for the current state of cancer policy confusion and consider whether pharmaceutical companies, for-profit cancer treatment hospitals, and interest groups like the American Cancer Society have a personal incentive to keep the fight alive.
Author : Institute of Medicine Publisher : National Academies Press Page : 95 pages File Size : 26,77 MB Release : 2013-06-20 Category : Medical ISBN : 030926944X
Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness.In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop.